PP-7-5 phase II study of paclitaxel (P) and eplrubicin (E) as first-line therapy in patients (PTS) with metastatic breast cancer (MBC)

1996 ◽  
Vol 32 ◽  
pp. 46
Author(s):  
Ch. Thomssen ◽  
H.-J. Lück ◽  
A. du Bois ◽  
B. Lisboa ◽  
M. Untch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

BMC Cancer ◽  
2005 ◽  
Vol 5 (1) ◽  
Author(s):  
Djelila Allouache ◽  
Sulochana R Gawande ◽  
Michele Tubiana-Hulin ◽  
Nicole Tubiana-Mathieu ◽  
Sophie Piperno-Neumann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Locally Recurrent

scholarly journals Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

2006 ◽  
Vol 94 (11) ◽  
pp. 1604-1609 ◽  
Author(s):  
F Ciardiello ◽  
T Troiani ◽  
F Caputo ◽  
M De Laurentiis ◽  
G Tortora ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document